

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | eosinophil chemotaxis (GO:0048245) | 5.19705598 |
| 2 | eosinophil migration (GO:0072677) | 4.63805861 |
| 3 | glycosphingolipid catabolic process (GO:0046479) | 4.42721563 |
| 4 | positive regulation of mast cell activation (GO:0033005) | 4.31442217 |
| 5 | cellular extravasation (GO:0045123) | 4.23679366 |
| 6 | positive regulation of mast cell degranulation (GO:0043306) | 4.11922198 |
| 7 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.11922198 |
| 8 | glycolipid catabolic process (GO:0019377) | 4.00417477 |
| 9 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98378165 |
| 10 | T-helper 1 type immune response (GO:0042088) | 3.96344834 |
| 11 | oligosaccharide catabolic process (GO:0009313) | 3.91851462 |
| 12 | regulation of mononuclear cell migration (GO:0071675) | 3.88709088 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 3.80124144 |
| 14 | ceramide catabolic process (GO:0046514) | 3.76872061 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 3.70975851 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60739367 |
| 17 | amino sugar catabolic process (GO:0046348) | 3.59438904 |
| 18 | positive regulation of heat generation (GO:0031652) | 3.54524367 |
| 19 | regulation of mast cell activation (GO:0033003) | 3.53311768 |
| 20 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.51884640 |
| 21 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.45032814 |
| 22 | positive regulation of chemokine secretion (GO:0090197) | 3.38353093 |
| 23 | N-acetylneuraminate metabolic process (GO:0006054) | 3.33117471 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.30646036 |
| 25 | regulation of antigen processing and presentation (GO:0002577) | 3.28372675 |
| 26 | activated T cell proliferation (GO:0050798) | 3.24322671 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.23099181 |
| 28 | membrane lipid catabolic process (GO:0046466) | 3.20620876 |
| 29 | angiotensin maturation (GO:0002003) | 3.20066831 |
| 30 | positive regulation of leukocyte degranulation (GO:0043302) | 3.19393482 |
| 31 | regulation of fever generation (GO:0031620) | 3.16970885 |
| 32 | sphingolipid catabolic process (GO:0030149) | 3.12499245 |
| 33 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.09323632 |
| 34 | regulation of mast cell degranulation (GO:0043304) | 3.07517049 |
| 35 | response to peptidoglycan (GO:0032494) | 3.06287663 |
| 36 | monocyte chemotaxis (GO:0002548) | 3.05627647 |
| 37 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.02535713 |
| 38 | negative regulation of macrophage differentiation (GO:0045650) | 3.02402778 |
| 39 | regulation of hypersensitivity (GO:0002883) | 2.97560745 |
| 40 | lytic vacuole organization (GO:0080171) | 2.97085376 |
| 41 | lysosome organization (GO:0007040) | 2.97085376 |
| 42 | regulation of heat generation (GO:0031650) | 2.96745794 |
| 43 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93061570 |
| 44 | mannose metabolic process (GO:0006013) | 2.92324197 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92321873 |
| 46 | intracellular pH reduction (GO:0051452) | 2.88978997 |
| 47 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.88182893 |
| 48 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85955175 |
| 49 | myeloid dendritic cell differentiation (GO:0043011) | 2.81481595 |
| 50 | keratan sulfate catabolic process (GO:0042340) | 2.81302177 |
| 51 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.77544516 |
| 52 | positive regulation of prostaglandin secretion (GO:0032308) | 2.77422443 |
| 53 | negative regulation of granulocyte differentiation (GO:0030853) | 2.77261076 |
| 54 | regulation of chemokine secretion (GO:0090196) | 2.73925119 |
| 55 | regulation of cholesterol storage (GO:0010885) | 2.71881247 |
| 56 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.69327129 |
| 57 | negative regulation of mast cell activation (GO:0033004) | 2.67888855 |
| 58 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67662076 |
| 59 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.64388869 |
| 60 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.63961595 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.63782516 |
| 62 | regulation of macrophage chemotaxis (GO:0010758) | 2.61962441 |
| 63 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.60347421 |
| 64 | cellular response to ethanol (GO:0071361) | 2.60189218 |
| 65 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60142933 |
| 66 | B cell mediated immunity (GO:0019724) | 2.59460509 |
| 67 | myeloid dendritic cell activation (GO:0001773) | 2.58328428 |
| 68 | pH reduction (GO:0045851) | 2.58292302 |
| 69 | granulocyte activation (GO:0036230) | 2.56846823 |
| 70 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.55082863 |
| 71 | response to protozoan (GO:0001562) | 2.53789235 |
| 72 | granulocyte chemotaxis (GO:0071621) | 2.52406032 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 2.52116193 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 2.52116193 |
| 75 | tryptophan catabolic process (GO:0006569) | 2.52116193 |
| 76 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.52041975 |
| 77 | apoptotic cell clearance (GO:0043277) | 2.52013255 |
| 78 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51741348 |
| 79 | modulation by symbiont of host defense response (GO:0052031) | 2.51741348 |
| 80 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51741348 |
| 81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51741348 |
| 82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51741348 |
| 83 | modulation by symbiont of host immune response (GO:0052553) | 2.51741348 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.51091603 |
| 85 | regulation of prostaglandin secretion (GO:0032306) | 2.48745837 |
| 86 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.47760559 |
| 87 | macrophage differentiation (GO:0030225) | 2.43290176 |
| 88 | microglial cell activation (GO:0001774) | 2.42141410 |
| 89 | granulocyte migration (GO:0097530) | 2.41343883 |
| 90 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.41142631 |
| 91 | cellular response to exogenous dsRNA (GO:0071360) | 2.41008709 |
| 92 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.40277060 |
| 93 | pinocytosis (GO:0006907) | 2.37132297 |
| 94 | regulation of interferon-alpha production (GO:0032647) | 2.36660193 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 2.36331223 |
| 96 | macrophage activation (GO:0042116) | 2.34826925 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 2.34329235 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.33946009 |
| 99 | negative regulation of interleukin-1 production (GO:0032692) | 2.33275870 |
| 100 | lipoxygenase pathway (GO:0019372) | 2.33183174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.22350356 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.24191521 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.72706775 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.37109882 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46434371 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.43801855 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.40520259 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.38881065 |
| 9 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38141640 |
| 10 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.28177982 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.02947142 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02076051 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85084435 |
| 14 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.80873814 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79453565 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74856780 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73511713 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71604057 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69560367 |
| 20 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69495301 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68766213 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67727069 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64356904 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62324441 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52788344 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50657021 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46398726 |
| 28 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.46229784 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42504610 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41094107 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38594918 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31294003 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31091800 |
| 34 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25098031 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20466188 |
| 36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17534874 |
| 37 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13938736 |
| 38 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10234968 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09876970 |
| 40 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09293951 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08899378 |
| 42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08164409 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06971183 |
| 44 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06896943 |
| 45 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06387448 |
| 46 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06328244 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06207059 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05924778 |
| 49 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05137098 |
| 50 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99792910 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99588510 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98310646 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97615168 |
| 54 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96445051 |
| 55 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94680393 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94075187 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92242119 |
| 58 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90473155 |
| 59 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88949486 |
| 60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88087866 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87867459 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.87533096 |
| 63 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.86331189 |
| 64 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.85697795 |
| 65 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.85697795 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85555700 |
| 67 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.85412034 |
| 68 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.82381828 |
| 69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81871229 |
| 70 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81346282 |
| 71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81041388 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80997234 |
| 73 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80997234 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80904653 |
| 75 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.80492373 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80351146 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80351146 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.80170093 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79491804 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79056853 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78966607 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 0.77261441 |
| 83 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76095003 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76001691 |
| 85 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.74134290 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72604336 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72399016 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72359841 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.72354351 |
| 90 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.72086578 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.71457089 |
| 92 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.71389835 |
| 93 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.71347788 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.71270768 |
| 95 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.71075265 |
| 96 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.71037821 |
| 97 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.71007728 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.70621725 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70493570 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69815968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.30602539 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.90071288 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.25985315 |
| 4 | MP0006082_CNS_inflammation | 3.09332290 |
| 5 | MP0003724_increased_susceptibility_to | 2.98352826 |
| 6 | MP0003303_peritoneal_inflammation | 2.98032932 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.78447950 |
| 8 | MP0005387_immune_system_phenotype | 2.76981322 |
| 9 | MP0001790_abnormal_immune_system | 2.76981322 |
| 10 | MP0000343_altered_response_to | 2.64310734 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.58935343 |
| 12 | MP0002419_abnormal_innate_immunity | 2.52082964 |
| 13 | MP0009840_abnormal_foam_cell | 2.44289066 |
| 14 | MP0009785_altered_susceptibility_to | 2.35189239 |
| 15 | MP0003436_decreased_susceptibility_to | 2.22497474 |
| 16 | MP0005025_abnormal_response_to | 2.22300752 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.08324035 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.04821263 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.04463130 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.02439410 |
| 21 | MP0003195_calcinosis | 2.01738909 |
| 22 | MP0000604_amyloidosis | 1.98026173 |
| 23 | MP0008004_abnormal_stomach_pH | 1.93855474 |
| 24 | MP0009764_decreased_sensitivity_to | 1.90824059 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.88903265 |
| 26 | MP0002723_abnormal_immune_serum | 1.87945773 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.85155161 |
| 28 | MP0003075_altered_response_to | 1.85003209 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.84569694 |
| 30 | MP0001800_abnormal_humoral_immune | 1.79414629 |
| 31 | MP0000685_abnormal_immune_system | 1.79158776 |
| 32 | MP0003011_delayed_dark_adaptation | 1.76436431 |
| 33 | MP0005365_abnormal_bile_salt | 1.65956952 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.62827199 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.62801034 |
| 36 | MP0001819_abnormal_immune_cell | 1.55498190 |
| 37 | MP0002405_respiratory_system_inflammati | 1.54514453 |
| 38 | MP0005647_abnormal_sex_gland | 1.53015177 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.52758540 |
| 40 | MP0005310_abnormal_salivary_gland | 1.50796688 |
| 41 | MP0008469_abnormal_protein_level | 1.44934379 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.43016421 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.41418448 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.37792051 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.31226163 |
| 46 | MP0004947_skin_inflammation | 1.27654760 |
| 47 | MP0005166_decreased_susceptibility_to | 1.25614941 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.20498007 |
| 49 | MP0005377_hearing/vestibular/ear_phenot | 1.16107168 |
| 50 | MP0003878_abnormal_ear_physiology | 1.16107168 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.13653830 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.12306899 |
| 53 | MP0004742_abnormal_vestibular_system | 1.10417713 |
| 54 | MP0004510_myositis | 1.09396929 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.06293991 |
| 56 | MP0003448_altered_tumor_morphology | 1.06025544 |
| 57 | MP0000920_abnormal_myelination | 1.04849871 |
| 58 | MP0010329_abnormal_lipoprotein_level | 1.04584365 |
| 59 | MP0001764_abnormal_homeostasis | 1.02517358 |
| 60 | MP0009115_abnormal_fat_cell | 1.02509257 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.00627938 |
| 62 | MP0000716_abnormal_immune_system | 0.98571377 |
| 63 | MP0001663_abnormal_digestive_system | 0.97265364 |
| 64 | MP0001853_heart_inflammation | 0.97002407 |
| 65 | MP0001542_abnormal_bone_strength | 0.96631044 |
| 66 | MP0003183_abnormal_peptide_metabolism | 0.95222975 |
| 67 | MP0001727_abnormal_embryo_implantation | 0.94709429 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.94322865 |
| 69 | MP0003690_abnormal_glial_cell | 0.94161830 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.94089530 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.94089530 |
| 72 | MP0002971_abnormal_brown_adipose | 0.92702604 |
| 73 | MP0001485_abnormal_pinna_reflex | 0.92481292 |
| 74 | MP0003279_aneurysm | 0.90521416 |
| 75 | MP0001958_emphysema | 0.89472302 |
| 76 | MP0003646_muscle_fatigue | 0.89285926 |
| 77 | MP0002254_reproductive_system_inflammat | 0.87751718 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.85169988 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.84349147 |
| 80 | MP0000371_diluted_coat_color | 0.84211970 |
| 81 | MP0004147_increased_porphyrin_level | 0.84051909 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 0.82569436 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.80948500 |
| 84 | MP0005360_urolithiasis | 0.80550629 |
| 85 | MP0003828_pulmonary_edema | 0.79030571 |
| 86 | MP0004130_abnormal_muscle_cell | 0.74381235 |
| 87 | MP0005334_abnormal_fat_pad | 0.74117670 |
| 88 | MP0002295_abnormal_pulmonary_circulatio | 0.73159926 |
| 89 | MP0002693_abnormal_pancreas_physiology | 0.72589667 |
| 90 | MP0005390_skeleton_phenotype | 0.72157061 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.71525788 |
| 92 | MP0009278_abnormal_bone_marrow | 0.71369261 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.71261150 |
| 94 | MP0005670_abnormal_white_adipose | 0.70087517 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.69983662 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.69907191 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.68148080 |
| 98 | MP0003879_abnormal_hair_cell | 0.67708061 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.67677786 |
| 100 | MP0003191_abnormal_cellular_cholesterol | 0.66561155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 8.96611836 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.85839320 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.81540870 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.81540870 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.81540870 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.48591709 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.12412174 |
| 8 | Mutism (HP:0002300) | 5.11718867 |
| 9 | Spontaneous hematomas (HP:0007420) | 4.82455427 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.45798545 |
| 11 | Dysostosis multiplex (HP:0000943) | 4.36653941 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.90878138 |
| 13 | Disinhibition (HP:0000734) | 3.76619012 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.62094761 |
| 15 | Loss of speech (HP:0002371) | 3.60864187 |
| 16 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.47927236 |
| 17 | Glomerulonephritis (HP:0000099) | 3.37966688 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.36582771 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.36582771 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.36582771 |
| 21 | Hematochezia (HP:0002573) | 2.97594341 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.96807783 |
| 23 | Mucopolysacchariduria (HP:0008155) | 2.96807783 |
| 24 | Protuberant abdomen (HP:0001538) | 2.95071296 |
| 25 | Complement deficiency (HP:0004431) | 2.83745628 |
| 26 | Axonal loss (HP:0003447) | 2.82041221 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.66397637 |
| 28 | Orchitis (HP:0100796) | 2.66045040 |
| 29 | Stomatitis (HP:0010280) | 2.61566411 |
| 30 | Inappropriate behavior (HP:0000719) | 2.60584833 |
| 31 | Recurrent skin infections (HP:0001581) | 2.58348789 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.58045441 |
| 33 | Optic neuritis (HP:0100653) | 2.55520313 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.55520313 |
| 35 | Myositis (HP:0100614) | 2.53245872 |
| 36 | Pustule (HP:0200039) | 2.51899025 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48185252 |
| 38 | Joint hemorrhage (HP:0005261) | 2.46988672 |
| 39 | Agnosia (HP:0010524) | 2.44659617 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42841228 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42841228 |
| 42 | Hemoptysis (HP:0002105) | 2.36015921 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 2.32259937 |
| 44 | Agitation (HP:0000713) | 2.31002469 |
| 45 | Abolished electroretinogram (ERG) (HP:0000550) | 2.29221286 |
| 46 | Bone cyst (HP:0012062) | 2.28325917 |
| 47 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.24025344 |
| 48 | Decreased circulating renin level (HP:0003351) | 2.23985963 |
| 49 | Esophageal varix (HP:0002040) | 2.23975341 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.23949543 |
| 51 | Congenital stationary night blindness (HP:0007642) | 2.23455762 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.20265321 |
| 53 | Steatorrhea (HP:0002570) | 2.20123846 |
| 54 | Progressive visual loss (HP:0000529) | 2.20050293 |
| 55 | Hydroxyprolinuria (HP:0003080) | 2.15677989 |
| 56 | Abnormality of proline metabolism (HP:0010907) | 2.15677989 |
| 57 | Nuclear cataract (HP:0100018) | 2.15335166 |
| 58 | Metaphyseal irregularity (HP:0003025) | 2.13747254 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.09070210 |
| 60 | Global brain atrophy (HP:0002283) | 2.06471234 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.04786071 |
| 62 | Enlarged epiphyses (HP:0010580) | 2.00586446 |
| 63 | Cardiomegaly (HP:0001640) | 2.00571088 |
| 64 | Albinism (HP:0001022) | 1.97562098 |
| 65 | Purpura (HP:0000979) | 1.96757227 |
| 66 | Amyloidosis (HP:0011034) | 1.96691715 |
| 67 | Ventricular fibrillation (HP:0001663) | 1.94420663 |
| 68 | Abnormality of complement system (HP:0005339) | 1.91732210 |
| 69 | Hepatosplenomegaly (HP:0001433) | 1.89761864 |
| 70 | Nephritis (HP:0000123) | 1.88943327 |
| 71 | Thoracic kyphosis (HP:0002942) | 1.87078812 |
| 72 | Diminished motivation (HP:0000745) | 1.85524647 |
| 73 | Hyperventilation (HP:0002883) | 1.85517236 |
| 74 | Polyneuropathy (HP:0001271) | 1.83700651 |
| 75 | Upper motor neuron abnormality (HP:0002127) | 1.81305888 |
| 76 | Flat occiput (HP:0005469) | 1.81268298 |
| 77 | Apathy (HP:0000741) | 1.80304504 |
| 78 | Premature loss of primary teeth (HP:0006323) | 1.77330627 |
| 79 | Ulnar claw (HP:0001178) | 1.76963493 |
| 80 | Dementia (HP:0000726) | 1.75536746 |
| 81 | Peripheral demyelination (HP:0011096) | 1.74718016 |
| 82 | Keratoconjunctivitis (HP:0001096) | 1.74105374 |
| 83 | Vasculitis (HP:0002633) | 1.73480042 |
| 84 | Encephalitis (HP:0002383) | 1.72771765 |
| 85 | Adactyly (HP:0009776) | 1.72494415 |
| 86 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.71781825 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 1.71724602 |
| 88 | Gingivitis (HP:0000230) | 1.70952201 |
| 89 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.69163959 |
| 90 | Memory impairment (HP:0002354) | 1.68534115 |
| 91 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67448319 |
| 92 | Congenital hepatic fibrosis (HP:0002612) | 1.66888072 |
| 93 | Fat malabsorption (HP:0002630) | 1.66609190 |
| 94 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66383135 |
| 95 | Cheilitis (HP:0100825) | 1.66099860 |
| 96 | Increased CSF protein (HP:0002922) | 1.65098273 |
| 97 | Basal ganglia calcification (HP:0002135) | 1.64804846 |
| 98 | Abnormal drinking behavior (HP:0030082) | 1.63617104 |
| 99 | Polydipsia (HP:0001959) | 1.63617104 |
| 100 | Petechiae (HP:0000967) | 1.63558968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.83565483 |
| 2 | ADRBK2 | 3.99604463 |
| 3 | ACVR1B | 3.39185838 |
| 4 | GRK7 | 3.17131316 |
| 5 | CAMKK2 | 2.65666913 |
| 6 | MAP3K14 | 2.52721919 |
| 7 | CSF1R | 2.40618222 |
| 8 | TGFBR2 | 2.35136532 |
| 9 | DAPK2 | 2.28589430 |
| 10 | TYK2 | 2.27146992 |
| 11 | CAMK1D | 2.24190019 |
| 12 | TXK | 2.11182730 |
| 13 | RIPK4 | 1.74925483 |
| 14 | TAOK3 | 1.72838022 |
| 15 | IKBKB | 1.70331745 |
| 16 | FRK | 1.64913807 |
| 17 | CAMK1G | 1.62394636 |
| 18 | MAP4K1 | 1.57891753 |
| 19 | GRK1 | 1.55911379 |
| 20 | MATK | 1.55844233 |
| 21 | DDR2 | 1.44292031 |
| 22 | MAP3K13 | 1.43604321 |
| 23 | CSK | 1.42980459 |
| 24 | SYK | 1.41326403 |
| 25 | ERN1 | 1.38916849 |
| 26 | NEK9 | 1.34548647 |
| 27 | CDC42BPA | 1.31668790 |
| 28 | TBK1 | 1.31057399 |
| 29 | INSRR | 1.29804309 |
| 30 | TGFBR1 | 1.27809784 |
| 31 | MAP3K11 | 1.23732194 |
| 32 | JAK3 | 1.21967390 |
| 33 | IRAK3 | 1.21313953 |
| 34 | FGR | 1.16676394 |
| 35 | LYN | 1.15762889 |
| 36 | PINK1 | 1.09307271 |
| 37 | IRAK4 | 1.07768286 |
| 38 | FES | 1.07205376 |
| 39 | CAMKK1 | 1.04659325 |
| 40 | KIT | 1.00607454 |
| 41 | IRAK1 | 0.99615151 |
| 42 | IKBKE | 0.95776959 |
| 43 | ADRBK1 | 0.92633031 |
| 44 | ZAP70 | 0.92229856 |
| 45 | BMPR1B | 0.89358747 |
| 46 | ITK | 0.88057012 |
| 47 | MAP3K9 | 0.87099306 |
| 48 | PIK3CG | 0.86115033 |
| 49 | ABL2 | 0.85214903 |
| 50 | LCK | 0.83439398 |
| 51 | PRKCQ | 0.82433272 |
| 52 | JAK1 | 0.80769892 |
| 53 | PNCK | 0.80274763 |
| 54 | PIM2 | 0.79535203 |
| 55 | MAPKAPK3 | 0.78555486 |
| 56 | CHUK | 0.78148474 |
| 57 | JAK2 | 0.78063583 |
| 58 | LIMK1 | 0.76399079 |
| 59 | MAP2K6 | 0.72859048 |
| 60 | RPS6KA6 | 0.70943064 |
| 61 | MAPK15 | 0.70235000 |
| 62 | TEC | 0.69247286 |
| 63 | BTK | 0.67963901 |
| 64 | RPS6KA2 | 0.66786001 |
| 65 | HCK | 0.66676066 |
| 66 | CASK | 0.65629449 |
| 67 | EPHB2 | 0.64779999 |
| 68 | OXSR1 | 0.63302958 |
| 69 | WNK4 | 0.62020286 |
| 70 | WNK3 | 0.61925171 |
| 71 | MAP4K2 | 0.59612777 |
| 72 | ABL1 | 0.58114408 |
| 73 | MOS | 0.57356784 |
| 74 | PTK2B | 0.55218305 |
| 75 | ZAK | 0.54799007 |
| 76 | TAOK1 | 0.54702945 |
| 77 | EPHA3 | 0.53800493 |
| 78 | PRKAA2 | 0.52556158 |
| 79 | TLK1 | 0.51990733 |
| 80 | CDK6 | 0.51704415 |
| 81 | PRKG2 | 0.51536857 |
| 82 | PDK1 | 0.47434517 |
| 83 | IGF1R | 0.47189919 |
| 84 | SIK2 | 0.47053967 |
| 85 | NME2 | 0.46528598 |
| 86 | NUAK1 | 0.45093984 |
| 87 | PDPK1 | 0.44533583 |
| 88 | SGK2 | 0.43949086 |
| 89 | RPS6KC1 | 0.43744146 |
| 90 | RPS6KL1 | 0.43744146 |
| 91 | TYRO3 | 0.43123715 |
| 92 | TNK2 | 0.41738570 |
| 93 | MARK3 | 0.38418839 |
| 94 | PRKACG | 0.37777149 |
| 95 | MAPK7 | 0.35822122 |
| 96 | PRKCG | 0.35163829 |
| 97 | MAP3K3 | 0.33974015 |
| 98 | PRKG1 | 0.33232149 |
| 99 | MAPK12 | 0.32422336 |
| 100 | TRPM7 | 0.32292413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.90712096 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.56781811 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.24080168 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.22367716 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.13912787 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.96282330 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.84442312 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.58797706 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.55546445 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.48838900 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27694406 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.26478120 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23373753 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.20718251 |
| 15 | * Tuberculosis_Homo sapiens_hsa05152 | 1.99187861 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.95520016 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90467956 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.82809706 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.71511272 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.68984923 |
| 21 | * Phagosome_Homo sapiens_hsa04145 | 1.57566535 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49314755 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.48441643 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43183599 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39510286 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27887902 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.26532234 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21206170 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.18077681 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16252101 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.15263315 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14999385 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14281847 |
| 34 | Mineral absorption_Homo sapiens_hsa04978 | 1.10252889 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09240748 |
| 36 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06117210 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.05635010 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04474074 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02250726 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00929860 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.91832234 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91451244 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83827935 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83292554 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.81650711 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79053768 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78089972 |
| 48 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77126831 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.75435510 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74291744 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71938356 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71177371 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69825603 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68849558 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68147364 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62913783 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.61387001 |
| 58 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61316549 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60752754 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54711945 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54528306 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.54021867 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52552846 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52066143 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50190474 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48613544 |
| 67 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46914097 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46598174 |
| 69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46419670 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41508945 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41269456 |
| 72 | Renin secretion_Homo sapiens_hsa04924 | 0.40942828 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38805390 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38370359 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38360429 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38046511 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37439329 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37360500 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.33898900 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33030518 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32826037 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.32595181 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29150289 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.28315250 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.27489011 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27353350 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27297253 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27085081 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25059356 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23333152 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23094811 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.21001945 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.20791611 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20545849 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.20227766 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.20074586 |
| 97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.19359777 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.18748725 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.18584557 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.17711538 |

